FARM BUSINESS NEWS
Washington Insider - Thursday
Thu Aug 21, 2014 06:13 AM CDT

Here's a quick monitor of Washington farm and trade policy issues from DTN's well-placed observer.

National Academies to Prepare New Report on Genetically Modified Organisms

The National Academies is putting together a new panel that will have the task of preparing a report that analyzes the experience with, and future prospects for, genetically engineered crops. The effort will be just the latest in a long series of studies and reports prepared and issued by the Academies.

The panel plans to update findings and questions raised in previous reports covering all aspects of GMO production. The panel's ...

Quick View
  • Stay on Top of SDS The distinctive yellow patches of sudden death syndrome (SDS) are surfacing in soybean fields acr...
  • Cattle Market There may be a little less bull in this fall's calf market, but the fundamentals still spell oppo...
  • Precision Ag Potential Pending Precision agriculture proponents insist the industry can revolutionize agriculture, but first mor...
  • Cash Rent Reset - 1 With sub-$4 corn forecast for multiple years, growers need to make a preemptive strike on their 2...
  • Iowa Land Gets a Bounce Key Midwest land values are stuck in neutral or sliding below 2014 levels, recently released opin...
  • Canadian Dairy Conundrum Coping with Canada's dairy industry import tariffs and supply controls remains one of the stickin...
  • Senior Partners - 5 This fatherly financial advice is meant to prevent heartaches should the farm economy suffer anot...
  • Ask the Taxman by Andy Biebl CPA Andy Biebl answers readers' questions on depreciation recapture, defining a "true" lease and ...
  • Ask the Vet Does my calf have a hernia and is it repairable?
Related News Stories
Washington Insider-- Friday
Ag Policy Blog
Rancher Asks Court: Stop EPA
Washington Insider-- Thursday
National Injunction Argued
Ozone Standard Questioned
Washington Insider
Washington Insider--Wednesday
California Drought Challenges
Activists Targeting Biotech